Bisphosphonate Side Effects: Cause For Growing Concern
(EMAILWIRE.COM, September 26, 2006 ) Englewood, CO -- They may be among the most-prescribed drugs in America, but bisphosphonates such as Fosamax, Actonel, Boniva and Zometa are also facing growing concerns about side effects including osteonecrosis of the jaw (ONJ), a rare syndrome in which jaw bone tissue dies. These bisphosphonate side effects directly contradict the drugs' intent, which is to strengthen bones and prevent bone loss in women and men with osteoporosis.
Bisphosphonates have come under fire in recent months after an article in the Annals of Internal Medicine linked the use of intravenous and tablet bisphosphonate drugs to ONJ in a variety of patients. Though the studies showed that intravenous use was the most dangerous, oral use is also a concern due to the long-term nature of most osteoporosis treatment. Though the Food and Drug Administration (FDA) has investigated bisphosphonate medications such as Fosamax and now requires more stringent labeling procedures for the drugs, the organization recently approved bisphosphonate drug Actonel for use in males and does not appear to be cracking down on drug manufacturers.
ONJ is an irreversible condition in which bone tissue dies and fails to regenerate and is often seen in patients who have had dental extractions or implants and oral surgery. Symptoms include pain and swelling, numbness in the jaw, exposed bone, and loose teeth. Patients who are starting bisphosphonate use for osteoporosis should tell their doctor if they anticipate having oral surgery.
Unfortunately, bisphosphonates have been linked with more than just bone death: the drugs are also associated with joint pain, allergic reactions, gastrointestinal distress and other symptoms. But with drugs such as Fosamax being prescribed over 22 million times in 2005 and the drugs' popularity spreading abroad, it does not appear that the bisphosphonate trend will end anytime soon.
To find out more about bisphosphonate side effects and unsafe drugs, visit LegalView.com, your resource for everything legal. LegalView has information and news on bisphosphonate use, bisphosphonate class action, bisphosphonate litigation, and bisphosphonate lawyers.
About LegalView.com
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation’s most highly respected law firms: Anapol Schwartz’ Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com’s superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.
Bisphosphonates have come under fire in recent months after an article in the Annals of Internal Medicine linked the use of intravenous and tablet bisphosphonate drugs to ONJ in a variety of patients. Though the studies showed that intravenous use was the most dangerous, oral use is also a concern due to the long-term nature of most osteoporosis treatment. Though the Food and Drug Administration (FDA) has investigated bisphosphonate medications such as Fosamax and now requires more stringent labeling procedures for the drugs, the organization recently approved bisphosphonate drug Actonel for use in males and does not appear to be cracking down on drug manufacturers.
ONJ is an irreversible condition in which bone tissue dies and fails to regenerate and is often seen in patients who have had dental extractions or implants and oral surgery. Symptoms include pain and swelling, numbness in the jaw, exposed bone, and loose teeth. Patients who are starting bisphosphonate use for osteoporosis should tell their doctor if they anticipate having oral surgery.
Unfortunately, bisphosphonates have been linked with more than just bone death: the drugs are also associated with joint pain, allergic reactions, gastrointestinal distress and other symptoms. But with drugs such as Fosamax being prescribed over 22 million times in 2005 and the drugs' popularity spreading abroad, it does not appear that the bisphosphonate trend will end anytime soon.
To find out more about bisphosphonate side effects and unsafe drugs, visit LegalView.com, your resource for everything legal. LegalView has information and news on bisphosphonate use, bisphosphonate class action, bisphosphonate litigation, and bisphosphonate lawyers.
About LegalView.com
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation’s most highly respected law firms: Anapol Schwartz’ Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com’s superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.
Contact Information:
LegalView
Peter Kent
Tel:
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
LegalView
Peter Kent
Tel:
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |